Search results
Results from the WOW.Com Content Network
Hair loss is a well-known side effect of many chemotherapy drugs used to treat certain forms of cancer. Similar to other toxins that cause hair loss, hair loss from cancer medications usually isn ...
Hypothermia caps appear useful to prevent hair loss during some kinds of chemotherapy, specifically when taxanes or anthracyclines are used. [6] It should not be used when cancer is present in the skin of the scalp or in people with lymphoma or leukemia. [7] There are generally only minor side effects from treatment. [8]
Permanent thinning or hair loss can result from some standard chemotherapy regimens. [101] Chemotherapy induced hair loss occurs by a non-androgenic mechanism, and can manifest as alopecia totalis, telogen effluvium, or less often alopecia areata. [102]
Hair loss, or alopecia, is a fairly common but not universal side effect of ABVD. Hair that is lost returns in the months after completion of chemotherapy. Nausea and vomiting can occur with ABVD, although treatments for chemotherapy-induced nausea and vomiting have improved substantially (see Supportive care below).
Of course, there are pros and cons to any hair loss treatment, procedure or surgery. ... The most common side effects of many of these weight loss medications include: Stomach pain or constipation.
Since chemotherapy affects the whole body, it can have a wide range of side effects. Patients often find that they start losing their hair since the drugs that are combatting the cancer cells also attack the cells in the hair roots. This powerful treatment can also lead to fatigue, loss of appetite, and vomiting depending on the person. [11]
Side effects from DHT blockers used in hair loss prevention shampoos are also uncommon. Some ingredients may cause irritation, dry skin, itchy skin or other similarly minor effects.
Common side effects include hair loss, bone marrow suppression, vomiting, rash, and inflammation of the mouth. [10] Other serious side effects may include allergic reactions such as anaphylaxis, heart damage, tissue damage at the site of injection, radiation recall, and treatment-related leukemia. [10]